BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9926263)

  • 1. Beta-blockers.
    Bursey RF
    Can J Gastroenterol; 1998; 12(8):542-3. PubMed ID: 9926263
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
    Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
    Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
    Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers in portal hypertension: new developments and controversies.
    Tripathi D; Hayes PC
    Liver Int; 2014 May; 34(5):655-67. PubMed ID: 24134058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-blockers and portal hypertension].
    Rueff B
    Rev Prat; 1984 Apr; 34(19):979-80. PubMed ID: 6144165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta-blockers in portal hypertension: Unexpected limitations!].
    Thevenot T; Cervoni JP; Di Martino V
    Presse Med; 2011 Mar; 40(3):227-9. PubMed ID: 21093210
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding.
    Lebrec D
    Hepatogastroenterology; 1990 Dec; 37(6):556-60. PubMed ID: 1981204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betablocker, hepatic functions and confusion.
    Bhalla A
    J Assoc Physicians India; 1999 Feb; 47(2):254-5. PubMed ID: 10999112
    [No Abstract]   [Full Text] [Related]  

  • 11. The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients.
    Sharma P; Kumar A; Jha S; Mishra SR; Sharma BC; Sarin SK
    Aliment Pharmacol Ther; 2010 Jul; 32(1):105-12. PubMed ID: 20345511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-adrenergic inhibitors and portal hypertension].
    Lebrec D
    Therapie; 1985; 40(6):403-6. PubMed ID: 2868535
    [No Abstract]   [Full Text] [Related]  

  • 14. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Propranolol and portal hypertension in cirrhotic patients. Manometric and hemodynamic studies].
    Reding P; Urbain D; Frère D; Thys O; Grivegnée A
    Acta Gastroenterol Belg; 1986; 49(3):324-8. PubMed ID: 3825447
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta blockaders and portal hypertension].
    Lebrec D
    Rev Prat; 1989 Apr; 39(13):1154-8. PubMed ID: 2567529
    [No Abstract]   [Full Text] [Related]  

  • 17. Carvedilol or propranolol in portal hypertension? A randomized comparison.
    Hobolth L; Møller S; Grønbæk H; Roelsgaard K; Bendtsen F; Feldager Hansen E
    Scand J Gastroenterol; 2012 Apr; 47(4):467-74. PubMed ID: 22401315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An advance in the treatment of portal hypertension?
    Wong F; Blendis L
    Gastroenterology; 2000 Apr; 118(4):802-3. PubMed ID: 10734033
    [No Abstract]   [Full Text] [Related]  

  • 19. Is treatment with nadolol effective against the growth of small esophageal varices in patients with cirrhosis?
    Bosch J
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):18-9. PubMed ID: 16265094
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-blockers to prevent gastroesophageal varices in cirrhosis.
    Post AB
    N Engl J Med; 2006 Mar; 354(12):1318-20; author reply 1318-20. PubMed ID: 16554538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.